24 Experts Forecast Future Trends In Immunology

“Where do you see the most important or interesting progress occurring in immunology over the next few years.” That was the question recently put to some two dozen senior immunologists by the editorial staff of the Institute for Scientific Information’s Atlas of Science: Immunology. The scientists surveyed—a distinguished, international group that represents academia, independent laboratories, and industry—serve as the editorial advisory board of the journal. In

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

“Where do you see the most important or interesting progress occurring in immunology over the next few years.” That was the question recently put to some two dozen senior immunologists by the editorial staff of the Institute for Scientific Information’s Atlas of Science: Immunology. The scientists surveyed—a distinguished, international group that represents academia, independent laboratories, and industry—serve as the editorial advisory board of the journal.

In general, these 24 scientists highlighted select areas that show good prospects for significant advances, such as the study of lymphokines and biological response modifers, T-cells, and auto-immunity. Here’s where the experts predict significant developments.

Lymphokine structure and function relationships. leading through x-ray crystallography to rational drug design.

Structure of peptide and protein mediators involved in immuno-regulation and design of molecules that mimic their activity.

Mapping precisely antigenic sites and upregulation of immune response against viruses and tumor antigens.

Cellular and molecular basis for T-cell ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies